SCHEMBL14927071

SCHEMBL14927071

C/C(N)=N/Cc1nc(-c2cccc(C(C)(C)C)c2)cc2cc(C)c(C)cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSS P25774 1/20 0.37
▸ CTSK P43235 1/20 0.37
▸ NOS1 P29475 3/20 0.34
▸ KIF11 P52732 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ NOS2 P35228 3/20 0.33
▸ NOS3 P29474 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ CTSA P10619 1/20 0.32
▸ TMEM97 Q5BJF2 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32
▸ IDO1 P14902 1/20 0.32
▸ RXRA P19793 2/20 0.32
▸ RXRB P28702 2/20 0.32
▸ KDM1A O60341 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ OPRD1 P41143 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14927019 0.92 CTSS (0.38) CTSSCTSKKIF11ALDH1A1CTSA
SCHEMBL14927018 0.90 KIF11 (0.39) CTSSCTSKKIF11ALDH1A1CTSA
SCHEMBL12071545 0.86 KDM4E (0.48) CTSSCTSKALDH1A1KDM4EMAPT
SCHEMBL14927016 0.83 ASIC1 (0.42) KIF11ALDH1A1RXRARXRBKDM4E
SCHEMBL14927111 0.83 CTSK (0.42) CTSSCTSKKIF11ALDH1A1CTSA
SCHEMBL14927103 0.81 KIF11 (0.40) CTSSCTSKKIF11ALDH1A1CTSA
SCHEMBL14927119 0.80 CTSS (0.42) CTSSCTSKKIF11ALDH1A1CTSA
SCHEMBL14927113 0.80 MAPKAPK2 (0.35) CTSSCTSKCYP3A4CTSARXRA
SCHEMBL14927120 0.80 CTSS (0.36) CTSSCTSKKIF11ALDH1A1CYP3A4
SCHEMBL14927104 0.79 MAPKAPK2 (0.35) CTSSCTSKCYP3A4CTSARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 CTSS 1995/4885CTSK 2530/4885NOS1 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback